Cargando…

Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity

BACKGROUND: To demonstrate treatment efficacy in Crohn’s disease (CD), regulatory authorities require that trials include an endoscopic remission/response end point; however, standardized endoscopic assessment of disease activity, such as the Simple Endoscopic Score for Crohn’s Disease (SES-CD), is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adler, Jeremy, Colletti, Richard B, Noonan, Lenore, Berzin, Tyler M, Cheifetz, Adam S, Conklin, Laurie S, Hoops, Timothy C, Huang, Christopher S, Lewis, Blair, Mishkin, Daniel S, Hung Lo, Kim, Xiao, Yongling, Volger, Sheri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320367/ https://www.ncbi.nlm.nih.gov/pubmed/36049024 http://dx.doi.org/10.1093/ibd/izac183

Ejemplares similares

Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
por: Zhang, Nanhua, et al.
Publicado: (2023)

Utility of Computed Tomographic Enteroclysis/Enterography for the Assessment of Mucosal Healing in Crohn's Disease
por: Hashimoto, Shinichi, et al.
Publicado: (2013)

Central endoscopy reads in inflammatory bowel disease clinical trials: The role of the imaging core lab
por: Ahmad, Harris, et al.
Publicado: (2014)

Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021)

Assessment of Inter-Laboratory Variation in the Characterization and Analysis of the Mucosal Microbiota in Crohn’s Disease and Ulcerative Colitis
por: Szamosi, Jake C., et al.
Publicado: (2020)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
por: Papamichael, Konstantinos, et al.
Publicado: (2017)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
por: Koga, Akihiro, et al.
Publicado: (2018)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Replacing Endoscopy with Magnetic Resonance Enterography for Mucosal Activity Assessment in Terminal Ileal Crohn’s Disease: Are We There Yet?
por: Bohra, Anuj, et al.
Publicado: (2023)

Mucosal healing assessment in Crohn’s disease with normalized iodine concentration from dual-energy CT enterography: comparison with endoscopy
por: Zhu, Chao, et al.
Publicado: (2023)

Clinical Outcome Assessments in Pediatric Patients With Ulcerative Colitis and Crohn’s Disease Receiving Biologics: A Retrospective Cohort Study
por: Hunter, Theresa, et al.
Publicado: (2022)

Research Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's Disease
por: Wang, Kuan, et al.
Publicado: (2016)

Assessment of Crohn’s disease activity by Doppler sonography
por: Na, Ying, et al.
Publicado: (2017)

Assessing Disease Activity in Pediatric Crohn’s Disease Using Ultrasound: The Pediatric Crohn Disease Intestinal Ultrasound Score
por: van Wassenaer, Elsa A., et al.
Publicado: (2023)

Dysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease
por: Li, Qiurong, et al.
Publicado: (2014)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

Targeting mucosal healing in Crohn’s disease: what the clinician needs to know
por: Klenske, Entcho, et al.
Publicado: (2019)

Mucosal Interleukin‐10 depletion in steroid‐refractory Crohn's disease patients
por: Carrasco, Anna, et al.
Publicado: (2022)

Characterization of the Mucosally-Adherent Duodenal Microbiome in Children with and without Crohn’s Disease
por: Schmidt, Kenneth, et al.
Publicado: (2022)

Imaging Modalities for the Noninvasive Assessment of Fibrosis in Crohn's Disease
por: Stasi, Cristina, et al.
Publicado: (2012)

Assessment of the Microbiota in Microdissected Tissues of Crohn's Disease Patients
por: De Hertogh, Gert, et al.
Publicado: (2012)

Recurrent pneumonia and colobronchial fistula from Crohn’s disease: Infliximab alters and simplifies surgical management
por: Mercadal, Nuria Rosa, et al.
Publicado: (2012)

Can the simplified magnetic resonance index of activity be used to evaluate the degree of activity in Crohn's disease?
por: Tao, Yongli, et al.
Publicado: (2021)

A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal Remission
por: Gremida, Anas, et al.
Publicado: (2021)

Inflammation-Induced Mucosal KYNU Expression Identifies Human Ileal Crohn’s Disease
por: Huhn, Meik, et al.
Publicado: (2020)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn’s disease
por: Chevalier, Grégoire, et al.
Publicado: (2021)

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
por: Zhang, Shiying, et al.
Publicado: (2022)

Mucosal DNA methylome alteration in Crohn’s disease: surgical and non-surgical groups
por: Ahmad, Saeed, et al.
Publicado: (2023)

Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn’s disease, and celiac disease
por: Braun, Tzipi, et al.
Publicado: (2023)

Assessing the feasibility of injectable growth-promoting therapy in Crohn’s disease
por: Altowati, Mabrouka A., et al.
Publicado: (2016)

Assessment of the usefulness of imaging studies and biomarkers in the activity of Crohn’s disease
por: Piotrowicz, Grażyna, et al.
Publicado: (2020)

Serum inflammatory markers in the diagnosis and assessment of Crohn’s disease activity
por: Słowińska-Solnica, Krystyna, et al.
Publicado: (2021)

Rapid assessment of malnutrition based on GLIM diagnosis in Crohn’s disease
por: Huang, Longchang, et al.
Publicado: (2023)

Simplified Assessment of the Index of Microvascular Resistance
por: Kodeboina, Monika, et al.
Publicado: (2021)

Mucosal p-STAT1/3 correlates with histologic disease activity in Crohn’s disease and is responsive to filgotinib
por: Reinisch, Walter, et al.
Publicado: (2022)

The Transcription Factor T-bet Regulates Mucosal T Cell Activation in Experimental Colitis and Crohn's Disease
por: Neurath, M.F., et al.
Publicado: (2002)

Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn’s disease
por: Chen, Jia-Min, et al.
Publicado: (2019)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
por: Szymanska, Edyta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_02ivdrt14j20vog3jp78tq35vv